Drug Manufacturers - Specialty & Generic stocks, ranked

Live ranking of 12 Drug Manufacturers - Specialty & Generic stocks by TickerMover Quant Score — a 0-100 composite of fundamentals, valuation, momentum, analyst signal, and macro regime. Click any ticker for the full breakdown.

These names score closely together — the group moves more as a block than as individual stories. These are descriptive measures of the group as it stands today, not a forecast and not a recommendation.

Ticker	Grade	Score	Bottom line
AMRX Amneal Pharmaceuticals, Inc.	B	63	Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
NBIX Neurocrine Biosciences, Inc.	B	62	Solid setup — 40% revenue growth, 3/4 EPS beats, 21% net margin. Momentum, fundamentals and macro indicators are aligned.
ELAN Elanco Animal Health Incorporated	B	61	Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
AMPH Amphastar Pharmaceuticals, Inc.	B	61	Setup looks favourable on the available data. Momentum, fundamentals and macro indicators are aligned.
ANIP ANI Pharmaceuticals, Inc.	C	59	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
VTRS Viatris Inc.	C	59	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
ZTS Zoetis Inc.	C	58	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LNTH Lantheus Holdings, Inc.	C	58	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
HIMS Hims & Hers Health, Inc.	C	57	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
ALKS Alkermes plc	C	55	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
UTHR United Therapeutics Corporation	C	52	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
COLL Collegium Pharmaceutical, Inc.	C	51	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.

Quant Scores update every 5 minutes during US market hours. Grades: A Top Tier · B Quality · C Average · D Below Avg · F Weak. (Quality descriptors, not buy/sell recommendations.)